THIOGUANINE VERSUS MERCAPTOPURINE FOR THERAPY OF CHILDHOOD LYMPHOBLASTIC-LEUKEMIA - A COMPARISON OF HEMATOLOGICAL TOXICITY AND DRUG METABOLITE CONCENTRATIONS
Dl. Lancaster et al., THIOGUANINE VERSUS MERCAPTOPURINE FOR THERAPY OF CHILDHOOD LYMPHOBLASTIC-LEUKEMIA - A COMPARISON OF HEMATOLOGICAL TOXICITY AND DRUG METABOLITE CONCENTRATIONS, British Journal of Haematology, 101, 1998, pp. 172-172